DNA Sequencing of Viral Gene Therapy Vectors During Pre-Clinical and Clinical Development

12/5/00


Click here to start


Table of Contents

PPT Slide

DNA Sequencing of Viral Gene Therapy Vectors During Pre-Clinical and Clinical Development

Forward Looking Statement

Vector Sequences: Dichotomy Between Belief and Reality

Method for Generating Ad5CMV-p53

Ad5CMV-p53: Starting Reagents

Ad5CMV-p53: Starting Reagents (continued)

Ad5CMV-p53 Sequence, Version 1

Ad5CMV-p53 Sequence, Version 1 (continued)

Ad5CMV-p53 Sequence, Version 1 (continued)

Ad5CMV-p53 Sequence

Ad5CMV-p53 Sequence, Version 2

Ad5CMV-p53 Sequence, Version 2 (continued)

Ad5CMV-p53 Sequence

Ad5CMV-p53 Sequence, Version 3

Ad5CMV-p53 Sequence, Version 3 (continued)

Ad5CMV-p53 Sequence, Version 3 (continued)

Ad5CMV-p53 Sequence, Version 3 (continued)

Ad5CMV-p53 Sequence, Version 3 (continued)

Ad5CMV-p53 Sequence, Version 3 (continued)

Ad5CMV-p53 Sequence

Conclusions

PPT Slide

 Author: Clara L. Burleson